ACSL3 is an androgen receptor (AR)-stimulated gene [37] and was recently identified in formalin-fixed prostate cancer tissue as a new 5′ translocation partner of ETS variant 1 (ETV1), an important gene in driving prostate cancer progression [38, 39]. This evidence concerns the gene ETV1 and prostate cancer.